期刊文献+

人附睾分泌蛋白4和糖类抗原125对卵巢癌诊断意义 被引量:8

Significance of serum human HE4 and CA125 for diagnosis of epithelial ovarian cancer
下载PDF
导出
摘要 目的探讨血清中人附睾分泌蛋白4(HE4)和糖类抗原125(CA125)在盆腔肿瘤中的临床诊断价值。方法选取56例卵巢癌、64例盆腔良性肿瘤、60例健康女性的血清标本,采用电化学发光免疫方法检测所有研究对象的血清HE4和CA125水平。结果卵巢癌组血清HE4(189.94pmol/L)与CA125(89.39U/L)表达水平明显高于盆腔良性肿瘤组(HE4=56.74pmol/L,CA125=45.11U/L)和健康对照组(HE4=46.36pmol/L,CA125=34.24U/L),差异有统计学意义(P<0.01)。卵巢癌不同病理分期的Ⅲ、Ⅳ期表达水平(HE4=236.25pmol/L,CA125=206.35 U/L)明显高于Ⅰ、Ⅱ期(HE4=96.36pmol/L,CA125=67.8U/L),差异有统计学意义(P<0.01)。以盆腔良性肿瘤组作为参照,HE4对卵巢癌的特异性、敏感性和阴性预测值、阳性预测值分别为85.71%、71.67%和73.84%、84.31%。HE4的特异性明显高于CA125(P<0.01);CA125对卵巢癌的敏感性(86.67%)高于HE4(71.67%),差异有统计学意义(P<0.01)。HE4曲线下面积(0.87)高于CA125(0.81)(P<0.01)。HE4与CA125联合检测明显提高特异性和阴性预测值,分别为95.15%和92.13%(P<0.01)。结论血清HE4对卵巢癌具有重要的临床诊断价值,其鉴别诊断效能优于CA125,且与CA125联合检测有助于提高卵巢癌的临床意义。 Objective To evaluate the value of HE4,CA125 in the diagnosis of epithelial ovarian cancer(EOC).Methods A total of 54 samples with epithelial ovarian cancer,64 suspicious benign pelvic mass,and 60 health controls were consecutively enrolled in this study.Results Good diagnostic performance in discriminating benign from EOC patients was obtained for CA125 and HE4.Serum level of HE4 of the patients in the three group were 189.94pmol/L,56.74pmol/L and 46.36pmol/L.Levels of CA125 were 89.39U/L,45.11U/L and 34.24U/L.There were stastically significant differences between the groups(P〈0.05).The serum HE4 and CA125levels of the patients with ovarian cancer at stageⅢ,Ⅳ(HE4=236.25pmol/L,CA125=206.35U/L)were significantly higher than the cases at stageⅠ,Ⅱ(HE4=96.36pmol/L,CA125=67.8U/L P〈0.05).Benign pelvic mass as control,the specificity(SP)was 86.6%,sensitivity(SN)was 82.6%,positive predictive value and negative predictive value of the serum HE4 were 85.71%,71.67%,73.84%,and 84.31% respectively.SN of CA125 was 86.67%,higher than that of HE4(71.67%,P〈0.01).The area under curves(AUC)of HE4 was 0.87 higher than that of CA125(0.81),(P〈0.01).Combing detection of ovarian cancer was higher than that of HE4 and CA125alone.SP was 95.15%,negative predictive value was 92.13%(P〈0.01).Conclusion Overall,the level of serum CA125 and HE4increase significantly,which showes well diagnostic performance to EOC from benign diseases.The combined detection of CA125 and HE4could improve the diagnostic power in cervical cancer prominently,so it has great reference value in the diagnosis of epithelial ovarian cancer.
出处 《国际检验医学杂志》 CAS 2016年第20期2805-2807,共3页 International Journal of Laboratory Medicine
基金 国家重大专项科研子课题(20120901000700002472)
关键词 人附睾分泌蛋白4 糖类抗原125 卵巢癌 盆腔肿瘤 CA125 HE4 epithelial ovarian cancer pelvic mass
  • 相关文献

参考文献12

  • 1Ferlay J, Soerjomataram I, Ervik M, et al. Globocan2012 vl. 0, cancer incidence and mortality worldwide: IARC cancer base No. 11[Internet] ,international agency for re- search on cancer, Lyon, France[EB/OL]. [2015-08-12]. http ..//globocan. iarc. fr.
  • 2Foster T. A review of the current evidence for mainte- nance therapy in ovarian cancer[J]. Gynecol OncoI, 2009, 115 (2) : 290-301.
  • 3Markmann S, Gerber B, Briese V. Prognostic value of Ca 125 levels during primary therapy [J]. Anticancer Res, 2007,27(4A):1837-1839.
  • 4Kirchhoff C. Molecular characterization of epididymal proteins[J]. Rev Reprod, 1998,3 (1) :86-95.
  • 5Drapkin R, von Horsten HH, Lin Y, et al. Human epidid- ymis protein4(HE4) is a secreted glycoprotein that is o- ver expressed by serous andendometrioid ovarian carcino- mas[J]. Cancer Res,2005,65(6):2162-2169.
  • 6雷震山,高鹏,吴金斌.联合检测血清HE4和CA125对卵巢癌患者的临床诊断价值探讨[J].国际检验医学杂志,2016,37(4):544-546. 被引量:20
  • 7Medeiros LR, Rosa DD, da Rosa MI, et al. Accuracy of CA 125 in the diagnosis of ovarian tumors: a quantitative systematic review[J]. Eur J Obstet Gynecol Reprod Biol, 2009,142(2) : 99-105.
  • 8Steffensen KD, Waldstrm M, Brandslund I, et al. The prognostic and predictive value of combined HE4 and CA-125 in ovarian cancer patients[J].Int J Gynecol Cancer, 2012,22 (9): 1474-1482.
  • 9Stiekema A, Lok CA, Kenter GG, et al. A predictive model combining human epididymal protein 4 and radiologic fea- tures for the diagnosis of ovarian cancer[J]. Gynecol On- :ol, 2014,132(3) : 573-537.
  • 10王耀楷.人附睾分泌蛋白4和CA125在卵巢癌早期诊断中的价值[J].医学综述,2015,21(9):1700-1702. 被引量:6

二级参考文献44

  • 1Oberaigner W,Minicozzi P,Bielska-Lasota M,et al.Survival for ovarian cancer in Europe:the across-country variation did not shrink in the past decade[J].Acta Oncol,2012,51(4):441-453.
  • 2Anderson GL,Mcintosh M,Wu L,et al.Assessing lead time of selected ovarian cancer biomarkers:a nestefd case-control study[J].J Natl Cancer Inst,2010,102(1):26-38.
  • 3Montagnana M,Danese E,Giudici S,et al.HE4 in ovarian cancer from discovery to clinical application[J].Adv Clin Chem,2011,55:1-20.
  • 4Cramer DW,Bast RC Jr,Berg CD,et al.Ovarian cancer biomarker performance in prostate,lung,colorectal,and ovarian cancer screening trial specimens[J].Cancer Prev Res(Phila),2011,4(3):365-374.
  • 5Kalogera E,Scholler N,Powless C,et al.Correlation of serum HE4with tumor size and myometrial invasion in endometrial cancer[J].Gynecol Oncol,2012,124(2):270-275.
  • 6Granato T,Midulla C,Longo F,et al.Role of HE4,CA72.4,and CA125 in monitoring ovarian cancer[J],Tumour Biol,2012,33(5):1335-1339.
  • 7Veigel D,Wagner R,Stübiger G,et al.Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells.International journal of cancer[J].Int J Cancer,2015,136(9):2078.
  • 8Sasaki A,Akita K,Ito F,et al.Difference in mesothelinbinding ability of serum CA125 between patients with endometriosis and epithelial ovarian cancer.International journal of cancer[J].Int J Cancer,2015,136(8):1985.
  • 9Vargas HA,MiccòM,Hong SI,et al.Association between Morphologic CT Imaging Traits and Prognostically Relevant Gene Signatures in Women with High-Grade Serous OvarianCancer:A Hypothesis-generating Study[J].Radiology,2015,274(3):742.
  • 10Kirchhoff C,Habben I,Lvell R,et al.A major human epididy- mis-spe-cific cDNA Encodes a protein with sequence homology to extracellu-Iar proteinase inhibitors[J].Biol Rcprod,1991,45(2):350-357.

共引文献31

同被引文献62

引证文献8

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部